Inviragen
-
IVI and Inviragen announce collaboration to accelerate development of dengue vaccine
The International Vaccine Institute (IVI) and Inviragen Inc announced the signing of a memorandum of understanding with the ultimate objective of making a dengue vaccine widely accessible to people in countries where this disease is endemic. The IVI,…
Inviragen | 04 August 2011
-
Inviragen initiates phase 1 study of HFMD vaccine in Singapore
Inviragen announced the initiation of the first clinical trial of the company’s proprietary hand, foot and mouth disease (HFMD) investigational vaccine, INV21. This is a highly purified virus particle preparation designed to protect against HFMD ca…
Inviragen | 17 June 2011
-
Inviragen Merges with SingVax
Inviragen and SingVax have merged their complementary vaccine pipelines and international product development capabilities. This is to create a company that is developing a range of vaccines for infectious diseases that are prevalent in emerging econ…
Inviragen | 07 October 2009
